Get started
koryu

NTLA long crispr/cas9

Long
Intellia Therapeutics, Inc. (NASDAQ:NTLA)  
koryu Updated   
NASDAQ:NTLA   Intellia Therapeutics, Inc.
6
0
buying NTLA as long term investment in crispr/cas9 technology.
Trade active
Comment:
bottom here would paint this channel
snapshot
Comment:
CRISPR stocks soar after chinese scientists start to crispr a human for the first time
Comment:
added to position in this last dip, inv h+s, crispr hot!!
Comment:
dump it -> go edit
Trade closed manually

Related Ideas

koryu
editas medicine crispr/cas9 investment
koryu about EDIT 3
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.